ANI Pharmaceuticals Inc. has appointed Peter A. Lankau to its board of directors. Currently Lankau is on the board of advisors of Orchard Venture Partners and chair of the board at Phosphagenics Ltd.
MELBOURNE – Promising clinical trial results for Phosphagenics Ltd. ’s transdermal analgesic patches have eased the pain of a year bruised by surprise allegations of fraud against the Melbourne bio
It may have been only a small Phase I trial, but investors in Phosphagenics were sufficiently convinced by positive results with a new transdermal formulation of oxymorphone to send shares in the Aust